Morad Tablet (Mosapride Citrate Hydrate)

Adult dose

Adults: Administer 15 mg of mosapride citrate anhydrous orally per day in 3 divided doses, before or after meals.

This drug contains lactose, so it should not be used in patients with genetic issues such as galactose intolerance, Lapp lactase deficiency, or glucose-galactose malabsorption. Adverse effects such as diarrhea, dry mouth, and malaise may occur while using this drug. Liver function issues can occur rarely, so if symptoms of liver dysfunction appear, use should be stopped immediately and a doctor should be consulted. There may be hypersensitivity reactions such as rashes or hives, and gastrointestinal symptoms such as abdominal bloating, nausea, vomiting, and taste disturbances may occur, requiring caution. The effectiveness of this drug may be reduced when taken with anticholinergics, so taking them at intervals is advisable. For women who are pregnant or may become pregnant, caution is required in using this drug, and during breastfeeding, it should be avoided if possible; in unavoidable cases, breastfeeding should be discontinued. The safety in pediatric patients has not been confirmed, so it is advisable not to use it in children. Elderly patients may have decreased kidney and liver function, so their condition should be well monitored and the dosage adjusted if necessary. This drug should be stored out of reach of children, and special care should be taken to avoid transferring it to another container as this may alter its quality.

• Diarrhea
• loose stools
• thirst
• lethargy
• eosinophilia
• increased triglycerides
• elevated AST
• elevated ALT
• elevated ALP
• elevated γ-GTP

This drug should be stored in a tightly sealed container to prevent air or moisture from entering. The storage temperature should be maintained between 1 degree and 30 degrees Celsius in a cool place.

Appearance

White, elliptical film-coated tablet

Package unit

30 tablets/bottle, 300 tablets/bottle